Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

The black orchid Brasiliorchis schunkeana produces chemicals that attract certain insects and have potential antimicrobial properties.

Mild oxidative stress can prevent hair loss from chemotherapy.

Marine microbes could be used in cosmetics for sun protection, skin care, and possibly preventing hair loss.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Topical vitamin D is effective in treating vitiligo with few side effects.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Minoxidil cream can safely treat hair loss in kids with ectodermal dysplasia.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

Eclipta prostrata has many medicinal benefits, but more research is needed to understand how it works.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Minoxidil boosts hair growth by increasing cell production and survival.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.